SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-320304
Filing Date
2018-11-07
Accepted
2018-11-07 09:07:58
Documents
4
Period of Report
2018-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d648784d8k.htm 8-K 15115
2 EX-99.1 d648784dex991.htm EX-99.1 36749
3 GRAPHIC g648784g75v04.jpg GRAPHIC 3846
4 GRAPHIC g648784g98l15.jpg GRAPHIC 5581
  Complete submission text file 0001193125-18-320304.txt   66404
Mailing Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5 604-629-9223
AQUINOX PHARMACEUTICALS, INC (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36327 | Film No.: 181164887
SIC: 2834 Pharmaceutical Preparations